Skip to main content
. Author manuscript; available in PMC: 2009 Jul 20.
Published in final edited form as: Radiat Res. 2009 May;171(5):596–605. doi: 10.1667/RR1632.1

FIG. 3.

FIG. 3

Effect of GT3 and/or mevalonate administration on mucosal surface area. TBI induced a reduction in mucosal surface area in all treatment groups (abbreviations as in Fig. 1). Administration of a single dose of GT3 24 h before irradiation significantly improved recovery of the intestinal mucosal surface area as measured from 7 days after irradiation on (P = 0.008). This effect was not reversed by mevalonate. The measures of variability (SE) are plotted only in the upward direction to minimize the number of overlapping lines.